The strong association of serum chemerin with comorbidities led us to individually analyze serum chemerin in patients suffering from hypertension, hypercholesterolemia or hyperuricemia and patients, which did not have these comorbidities. Here, RARRES2 is linked to familial hypercholesterolemia.